038460 — BioSmart Co Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapContrarian

Annual cashflow statement for BioSmart Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	634	-1,182	16,179	1,055	8,986
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	10,056	11,345	-1,422	19,086	14,367
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-13,981	-14,132	-22,081	-24,547	-5,116
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,328	5,587	1,166	3,798	25,673
Capital Expenditures	-5,754	-5,867	-4,917	-8,661	-33,765
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-26,043	154	-3,917	-164	16,934
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-31,797	-5,714	-8,834	-8,825	-16,831
Financing Cash Flow Items	0	—	-150	5,946	-10,898
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	24,596	6,193	8,910	-5,025	10,326
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4,843	6,027	1,239	-10,040	19,210